We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$500M
AUM Growth
-$80.8M
Cap. Flow
-$34.9M
Cap. Flow %
-6.99%
Top 10 Hldgs %
34.04%
Holding
671
New
64
Increased
221
Reduced
213
Closed
46

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$9.36M
2
MT icon
ArcelorMittal
MT
+$8.22M
3
T icon
AT&T
T
+$7.11M
4
BUD icon
AB InBev
BUD
+$5.34M
5
BCE icon
BCE
BCE
+$4.96M

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.51%
2 Communication Services 11.94%
3 Materials 10.5%
4 Consumer Discretionary 9.71%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CM icon
426
CALL
Canadian Imperial Bank of Commerce
CM
$103B
$7.75K ﹤0.01%
1,000
GOLD
427
DELISTED
Randgold Resources Ltd
GOLD
$7.56K ﹤0.01%
92
INTU icon
428
Intuit
INTU
$88B
$7.02K ﹤0.01%
41
-221
-84% -$37.2K
CC icon
429
Chemours
CC
$2.21B
$6.94K ﹤0.01%
149
WAB icon
430
Wabtec
WAB
$47B
$5.66K ﹤0.01%
71
TRI icon
431
Thomson Reuters
TRI
$44.5B
$5.31K ﹤0.01%
119
FTR
432
DELISTED
Frontier Communications Corp.
FTR
$4.4K ﹤0.01%
607
-1,384
-70% -$10.8K
BUD icon
433
CALL
AB InBev
BUD
$156B
$4.05K ﹤0.01%
450
-1,220
-73% -$135K
GGAL icon
434
Galicia Financial Group
GGAL
$6.77B
$3.61K ﹤0.01%
56
+53
+1,767% +$3.48K
FL
435
DELISTED
Foot Locker
FL
$3.61K ﹤0.01%
81
-17,691
-100% -$823K
GRPN icon
436
Groupon
GRPN
$762M
$3.51K ﹤0.01%
40
+20
+100% +$1.94K
EW icon
437
Edwards Lifesciences
EW
$49.4B
$3.01K ﹤0.01%
66
-3,573
-98% -$155K
NVR icon
438
NVR
NVR
$16.7B
$2.98K ﹤0.01%
1
ILF icon
439
iShares Latin America 40 ETF
ILF
$3.92B
$2.53K ﹤0.01%
69
LIVN icon
440
LivaNova
LIVN
$4.38B
$2.35K ﹤0.01%
47
VMW
441
DELISTED
VMware, Inc
VMW
$2.28K ﹤0.01%
19
-24
-56% -$3.02K
NEWR
442
DELISTED
New Relic, Inc.
NEWR
$2.26K ﹤0.01%
31
-5,161
-99% -$346K
FFIV icon
443
F5
FFIV
$24.4B
$2.15K ﹤0.01%
15
-26
-63% -$3.73K
NBIX icon
444
Neurocrine Biosciences
NBIX
$15.2B
$2.02K ﹤0.01%
25
-140
-85% -$11.8K
MDY icon
445
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$2.02K ﹤0.01%
6
RYN icon
446
Rayonier
RYN
$6.08B
$2.02K ﹤0.01%
63
-5
-7% -$152
PSA icon
447
Public Storage
PSA
$55.4B
$2.02K ﹤0.01%
10
+1
+11% +$195
BIDU icon
448
Baidu
BIDU
$30.9B
$2K ﹤0.01%
9
CBRE icon
449
CBRE Group
CBRE
$40.6B
$1.91K ﹤0.01%
41
-7
-15% -$319
MFA
450
MFA Financial
MFA
$852M
$1.91K ﹤0.01%
65
+6
+10% +$178

Similar funds

Exane Derivatives's Q1 2018 Portfolio in Review

As of Q1 2018, Exane Derivatives held 671 positions worth $500M, down 14% from $581M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Exane Derivatives withdrew a net $34.9M in Q1 2018, closing 46 positions and reducing 213 holdings. Its most notable exit was UBS Group, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 39% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Exane Derivatives opened a new position in AB InBev worth $5.29M.

  • Exane Derivatives's largest Q1 2018 buy was AB InBev: 48,192 shares worth $5.29M.
  • Exane Derivatives added most to PepsiCo in Q1 2018, an estimated $9.36M increase.
  • Exane Derivatives's biggest Q1 2018 reduction was iShares China Large-Cap ETF, cutting an estimated $43.3M.
  • Exane Derivatives fully exited UBS Group in Q1 2018, selling an estimated $34.3M.
  • Exane Derivatives's ten largest holdings make up 34% of its $500M portfolio in Q1 2018.
  • Exane Derivatives opened 64 new positions and closed 46 in Q1 2018.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $500M.

Based on Exane Derivatives's 13F filing for Q1 2018, filed 30 Apr 2018.